SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
AHR reported Third Quarter 2026 results. The stock moved +3.3% on the print.
AHRearnings

Earnings reactions, page 5

American Healthcare REIT, Inc. (AHR) Q3 FY2026 earnings

November 6, 2026 · SharpeIQ Research Desk

Reported results

  • GAAP net income attributable to controlling interest was $31.2 million, or $0.14 per diluted share, for the third quarter of 2026.
  • Normalized Funds From Operations attributable to controlling interest (“NFFO”) (non-GAAP) was $0.58 per diluted share for the third quarter of 2026.
  • NAREIT FFO per common share attributable to controlling interest — diluted (non-GAAP) was $0.55 for the third quarter of 2026.
  • Total portfolio Same-Store Net Operating Income (“Same-Store NOI”) growth (non-GAAP) was 13.8% for the three months ended September 30, 2026.
  • Total GAAP revenues were $742,149 thousand for the three months ended September 30, 2026.

Guidance

  • For full year 2026, expected GAAP net income per common share — diluted is $0.59 to $0.62.
  • For full year 2026, expected NAREIT FFO per common share — diluted (non-GAAP) is $2.13 to $2.16.
  • For full year 2026, expected Normalized FFO per common share — diluted (non-GAAP) is $2.23 to $2.26.
  • For full year 2026, expected Total Portfolio Same-Store NOI growth (non-GAAP) is 12.0% to 14.0%.

Price and volatility reaction

The stock moved +3.3% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -7.5 vol points across the event (constant-maturity series — not the front-week crush).

MeasureValueBasis
Close before release56.042026-11-05
Close after release57.912026-11-06
Realised move+3.3%close to close
30d ATM IV change-7.5 vol ptsconstant-maturity series, not the front expiry
Price and volatility reaction. Closes either side of the release. No front-expiry chain on file for a straddle expected move. SharpeIQ — listed option chain and price_history

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →